SHOX2 and neoplasm: In this study, we describe the integration of this new technology into our routine pathological detection process and evaluate the diagnostic efficiency of SHOX2 and RASSF1A methylation in broncho-exfoliated cells, comparing it with conventional cytology TCT examination, histology, immunohistochemistry, and serum tumor markers.